EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Targeting Mitochondria and Oxidative Stress in Cancer- and Chemotherapy-Induced Muscle Wasting

Joshua R Huot, Dryden Baumfalk, Aridai Resendiz, Andrea Bonetto, Ashley J Smuder, Fabio Penna iD

Antioxidants & Redox Signaling · 2023-02 · 38 (4-6) · 352-370

DOI: 10.1089/ars.2022.0149 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antioxidants & Redox Signaling, online erschienen am 14.02.2023. Verfasst von Joshua R Huot und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery and Indiana University School of Medicine, Indianapolis, Indiana, USA. Hauptthemen laut MEDLINE: Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 196 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAMS NIH HHS, NIDDK NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Significance: Cancer is frequently associated with the early appearance of cachexia, a multifactorial wasting syndrome. If not present at diagnosis, cachexia develops either as a result of tumor progression or as a side effect of anticancer treatments, especially of standard chemotherapy, eventually representing the direct cause of death in up to one-third of all cancer patients. Cachexia, within its multiorgan affection, is characterized by severe loss of muscle mass and function, representing the most relevant subject of preclinical and clinical investigation. Recent Advances: The pathogenesis of muscle wasting in cancer- and chemotherapy-induced cachexia is complex, and encompasses heightened protein catabolism and reduced anabolism, disrupted mitochondria and energy metabolism, and even neuromuscular junction dismantling. The mechanisms underlying these alterations are still controversial, especially concerning the molecular drivers that could be targeted for anticachexia therapies. Inflammation and mitochondrial oxidative stress are among the principal candidates; the latter being extensively discussed in the present review. Critical Issues: Several approaches have been tested to modulate the redox homeostasis in tumor hosts, and to counteract cancer- and chemotherapy-induced muscle wasting, from exercise training to distinct classes of direct or indirect antioxidants. We herein report the most relevant results obtained from both preclinical and clinical trials. Future Directions: Including the assessment and the treatment of altered redox balance in the clinical management of cancer patients is still a big challenge. The available evidence suggests that fortifying the antioxidant defenses by either pharmacological or nonpharmacological strategies will likely improve cachexia and eventually the outcome of a broad cancer patient population. Antioxid. Redox Signal. 38, 352–370.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsAntineoplastic AgentsHumansCachexiaMuscle, SkeletalMuscular AtrophyMitochondriaOxidative Stress

Stichwörter der Autor:innen

antioxidantscancerchemotherapynutraceuticalswasting

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Surgery and Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Department of Cell Biology & Physiology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Department of Applied Physiology and Kinesiology, University of Florida, Gainesville, Florida, USA.
  • Department of Oncology, Surgical Oncology and Digestive Surgery Unit, S Luigi University Hospital, University of Torino, Torino, Italy.
  • Department of Otolaryngology-Head & Neck Surgery, Indiana University School of Medicine, Indianapolis, Indiana, USA.
  • Indiana Center for Musculoskeletal Health, and Indiana University School of Medicine, Indianapolis, Indiana, USA.

ORCID-Profile: Fabio Penna

Förderung

  • NIAMS NIH HHS
  • NIDDK NIH HHS
  • NHLBI NIH HHS

Zitieren

APA

Huot, J. R., Baumfalk, D., Resendiz, A., Bonetto, A., Smuder, A. J., & Penna, F. (2023). Targeting Mitochondria and Oxidative Stress in Cancer- and Chemotherapy-Induced Muscle Wasting. Antioxidants & Redox Signaling, 38(4-6), 352-370. https://doi.org/10.1089/ars.2022.0149

Vancouver

Huot JR, Baumfalk D, Resendiz A, Bonetto A, Smuder AJ, Penna F. Targeting Mitochondria and Oxidative Stress in Cancer- and Chemotherapy-Induced Muscle Wasting. Antioxidants & Redox Signaling. 2023;38(4-6):352-370. doi:10.1089/ars.2022.0149

BibTeX
@article{Huot2023,
  author = {Huot, Joshua R and Baumfalk, Dryden and Resendiz, Aridai and Bonetto, Andrea and Smuder, Ashley J and Penna, Fabio},
  title = {Targeting Mitochondria and Oxidative Stress in Cancer- and Chemotherapy-Induced Muscle Wasting},
  journal = {Antioxidants & Redox Signaling},
  year = {2023},
  volume = {38},
  number = {4-6},
  pages = {352--370},
  doi = {10.1089/ars.2022.0149}
}
Kostenlos starten →